Patrick Soon-Shiong
Patrick Soon-Shiong
Patrick Soon-Shiongis a South African surgeon, medical researcher, businessman, philanthropist, and professor at University of California at Los Angeles. He is currently chairman of the Chan Soon-Shiong Family Foundation and chairman and CEO of the Chan Soon-Shiong Institute for Advanced Health, National LambdaRail, the Healthcare Transformation Institute and NantWorks, LLC. In October 2010, he bought Earvin "Magic" Johnson's minority ownership stake in the Los Angeles Lakers...
NationalitySouth African
ProfessionBusinessman
Date of Birth29 July 1952
I am convinced that in order for you, as a patient, to be protected, it has to be transparent, evidence-based, objective information. Not self-serving information. Not pharma-driven information. Not ad-driven information. It is transparent, objective, evidence-based information.
We know that if you just were to take the drugs that you were supposed to take for diabetes or hypertension, just take it, as opposed to not take it, we could save $7,000, $3,000 per patient per year.
We need to think of chronic disease, hypertension, cancer, like H1N1. In fact, there's an epidemic of chronic disease.
It's unconscionable that cancer patients get the wrong diagnosis 30 percent of the time and that it takes so long to treat them with appropriate drugs for their cancer.
I was working with stem cells as part of a NASA programme. We realised that the science of stem-cell proliferation was also fundamental to cancer cells when cancer enters the phase of metastasis.
If you look upon chronic diseases as an epidemic, and you see that the chronically ill are the poor, then you see that this issue of the uninsured is not really a moral but a financial obligation to change health care.
You don't inherit cancer; you actually get it.
Cancer is really a slew of rare diseases. Lung cancer has 700 sub-types, breast cancer has 30,000 mutations which means that every cancer in its own right is a rare disease. Sharing data globally in this context is really important from a life-threatening perspective.
What we discovered, counter-intuitively, is that when you start killing a cancer cell, one of the things it does in order to survive is to spread even further. It causes itself to form new blood vessels. We've termed this 'reactionary angiogenesis.'